Paediatric cancer breakthrough in Qatar: Sidra Medicine introduced two specialised anti-GD2 therapies for children with high-risk neuroblastoma—naxitamab (Danyelza) first in the GCC and dinutuximab beta (Qarziba) first in Qatar—administered to patients after stem cell transplant, marking a major step for paediatric oncology access. Breast cancer screening push: PHCC launched its annual breast cancer awareness campaign for October, urging women to get screened early under the “Your strength begins with screening” message, with a nationwide “Screen for Life” focus on prevention and higher survival when caught promptly. Advanced dental surgery at HMC: Hamad Medical Corporation performed Qatar’s first advanced subperiosteal jaw implant and reconstruction using virtual planning and 3D simulation, offering new options for patients previously considered ineligible for conventional implants. Health emergency funding abroad: The US hosted a G20 foreign ministers meeting that secured $470m in new commitments to tackle the Ebola outbreak in the DRC, with donors including Qatar, as response efforts scale up vaccines, diagnostics and treatment capacity. Local health system training: Qatar Career Development Center’s Career Village welcomed 3,240 secondary students for hands-on career exploration, including inclusion for students with special needs—supporting future healthcare and public-sector talent.